Generis Global Partners, dans le cadre de sa vente à 17208227 Canada Inc., une filiale d’Emerald X
Mac Chain Company in its US$31.4-million sale to Renold pursuant to an asset and share purchase agreement
Medicus Pharma Ltd., (TSXV: MDCX; NASDAQ: MDCX), in its US IPO and NASDAQ-listing